Identification of enzymes involved in the metabolism of 17α-hydroxyprogesterone caproate: An effective agent for prevention of preterm birth

Drug Metabolism and Disposition

Volumn 36, Issue 9, 2008, Pages 1896-1902

  Sharma, Shringi ^a   Ou, Junhai ^a   Strom, Stephen ^b   Mattison, Don ^c   Caritis, Steve ^d   Venkataramanan, Raman ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA NAPHTHOFLAVONE; COUMARIN; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; HEXANOIC ACID; HYDROXYPROGESTERONE CAPROATE; KETOCONAZOLE; PHENOBARBITAL; QUINIDINE; RIFAMPICIN; SULFAPHENAZOLE; THIAMAZOLE; TROLEANDOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CELL; LIVER MICROSOME; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MICROSOMES, LIVER; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PROGESTERONE; SPECTROPHOTOMETRY, ULTRAVIOLET; TANDEM MASS SPECTROMETRY;

EID: 50049101707     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.021444     Document Type: Article

References (17)

1. Attardi BJ, Zeleznik A, Simhan H, Chiao JP, Mattison DR, and Caritis SN (2007) Comparison of progesterone and glucocorticoid receptor binding and stimulation of gene expression by progesterone, 17-alpha hydroxyprogesterone caproate, and related progestins. Am J Obstet Gynecol 197:599.e591- e597.
2. Caritis S and Venkataramanan R (2007) Pharmacokinetics of 17-alpha hydroxyprogesterone caproate in women with twin gestation. Reprod Sci Suppl 14:294.
3. Chiba M, Hensleigh M, Nishime JA, Balani SK, and Lin JH (1996) Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos 24:307-314.
4. Court MH and Greenblatt DJ (1997) Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes. Biochem Pharmacol 53:1041-1047.
5. Kobayashi K, Mimura N, Fujii H, Minami H, Sasaki Y, Shimada N, and Chiba K (2000) Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Clin Cancer Res 6:3297-3303.
6. Kostrubsky VE, Ramachandran V, Venkataramanan R, Dorko K, Esplen JE, Zhang S, Sinclair JF, Wrighton SA, and Strom SC (1999) The use of human hepatocyte cultures to study the induction of cytochrome P-450. Drug Metab Dispos 27:887-894.
7. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
8. Mattison DR, Damus K, Fiore E, Petrini J, and Alter C (2001) Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 15(Suppl 2):7-16.
9. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, et al. (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348:2379-2385.
10. Nelson AC, Huang W, and Moody DE (2001) Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation. Drug Metab Dispos 29:319-325.
11. Paneth NS (1995) The problem of low birth weight. Future Child 5:19-34.
12. Rendic S and Di Carlo FJ (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413-580.
13. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD, and Schuetz EG (1996) Use of human hepatocytes to study P450 gene induction. Methods Enzymol 272:388-401.
14. Tracy TS, Venkataramanan R, Glover DD, Caritis S, for the National Institute for Child Health and Human Development Network of Maternal-Fetal- Medicine Units (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192:633-639.
15. Wrighton SA, Brian WR, Sari MA, Iwasaki M, Guengerich FP, Raucy JL, Molowa DT, and Vandenbranden M (1990) Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 38:207-213.
16. Wu DH and Allen WM (1959) Maintenance of pregnancy in castrated rabbits by 17-alphahydroxy-progesterone caproate and by progesterone. Fertil Steril 10:439-460.
17. Yan R, Nanovskaya TN, Zharikova OL, Mattison DR, Hankins GD, and Ahmed MS (2008) Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons. Biochem Pharmacol 75:1848-1857.